New medications have transformed obesity treatment, but the science behind them points to an even more personalized future of care.
Estimated reading time:4minutes
We are living through a remarkable period in obesity medicine.
For decades, people living with obesity have faced the misconception that their disease is simply the result of eating too much or exercising too little. Science has shown us something very different. Obesity is a complex, chronic disease, influenced by biology and many other factors that affect how our bodies regulate weight and metabolism.
Today, our understanding of that complexity is growing rapidly, and it is changing how we think about treatment.
A turning point in treatment
The emergence of highly effective obesity medications, including glucagon-like peptide-1 receptor agonists, has transformed the treatment landscape. These therapies have also brought unprecedented public attention to obesity and helped demonstrate something scientists in our field have understood for years: Biology plays a powerful role in body weight.
But today’s medications are not the end of the story. In many ways, they are the beginning of a new era.
The future of obesity care will not be defined by a single medication, procedure, or scientific breakthrough. It will be shaped by our growing understanding of the many biological mechanisms involved in obesity and our ability to translate that knowledge into more individualized and comprehensive treatment.
As an adipocyte biologist who has spent more than 35 years studying fat cells, I have watched our understanding of fat tissue and obesity evolve dramatically. We continue to learn more about adipose tissue, hormones, metabolism, the brain, and the complex biological systems that regulate food intake, energy use, and body weight.
Each discovery creates new questions and new possibilities.
Moving toward more personalized care
In the years ahead, we can expect obesity treatment to continue expanding beyond the options available today. Researchers are investigating new therapeutic targets and studying how different biological pathways contribute to obesity. Just as importantly, scientists and clinicians are working to better understand why individuals respond differently to treatment and how we can use that knowledge to provide more personalized care.
That evolution matters because there is no single experience of obesity, and there will not be a single solution.
Medication may be appropriate for some people. Others may benefit from metabolic and bariatric surgery, nutrition interventions, physical activity, behavioral support, or combinations of different approaches. As the science advances, clinicians will have more tools available to help determine the approach that best meets an individual’s needs.
Making sure progress reaches patients
Progress must also extend beyond developing new treatments. We need to ensure that scientific advances reach the people who can benefit from them. That means continuing to address barriers to evidence-based obesity care and confronting the stigma that still surrounds this disease.
For more than four decades, The Obesity Society has brought together scientists and clinicians who recognize obesity as a complex disease deserving rigorous scientific study. That community now includes people studying everything from basic biology and neuroscience to clinical treatments and the many factors that influence health.
At ObesityWeek® 2026, we will see many of these areas of research come together, from emerging treatments and biological discoveries to new approaches to clinical care. But the larger story extends well beyond any one scientific meeting.
We are moving toward a future in which obesity is better understood, treatment options are broader, and care can increasingly reflect the biology and needs of each individual.
There is still much we do not know, but that is also what makes this moment so exciting. Some of the most important discoveries in obesity treatment are likely still ahead of us.
1 Comment